Emma Andrus, Editor

Christopher Bunick, MD, PhD, discusses the evolving role of OX40-targeted biologics in atopic dermatitis treatment ahead of the upcoming RAD conference.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Collagen structure and vessel density vary by photoaging type, highlighting the value of multimodal imaging in guiding individualized skin care strategies.

New findings reveal DecisionDx-Melanoma more accurately identifies patients with under 5% risk of SLN positivity, supporting safer avoidance of SLNB surgery.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

The social media campaign aims to educate, inspire prevention, and support actinic keratosis awareness leading up to Global AK Awareness Day on May 24.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of May.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Dermatology Times is looking back on the top stories in dermatology from the month of April.

This review of the latest dermatologic studies includes insights into the environmental impact of dermatology, submicrobial dosing of antibiotics in dermatology, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Acting upstream of cytokines may hold the key to improving biologic efficacy and itch relief in AD.

Dermatology Times is recapping our exclusive expert interviews from the month of April.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Learn more about the in-depth topics covered in the April 2025 print issue of Dermatology Times.

A new study reveals ongoing burden of moderate to severe atopic dermatitis in youth, with flares, comorbidities, and quality of life impacts.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

VYNE Therapeutics paused its VYN202 trial for psoriasis due to an FDA-issued clinical hold.

Discover how the RAD conference in Nashville enhances atopic dermatitis care, featuring expert insights and patient-focused strategies for clinicians.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

AbbVie seeks FDA approval for TrenibotE, a first-in-class botulinum toxin offering fast onset and short duration for glabellar lines.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Paller discusses the promising phase 3 trial SELVA trial results for Qtorin 3.9% rapamycin gel, an investigative treatment for microcystic lymphatic malformations.

This review of the latest dermatologic studies includes insights into epidermolysis bullosa for primary care providers, patient-reported impact of atopic dermatitis on pediatric and adolescent patients, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Palvella has secured its 5th US patent for Qtorin rapamycin, extending intellectual property coverage to 2038 and advancing treatment for microcystic lymphatic malformations.

A survey by LEO Pharma indicates widespread misunderstandings about chronic hand eczema, revealing significant emotional and occupational challenges for patients.